This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Dupont AW, Arguedas MR, Wilcox CM.Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. Alimentary Pharmacology and Therapeutics 26: 431-441, No. 3, 1 Aug 2007
Rights and permissions
About this article
Cite this article
Aspirin plus colonoscopy worth it for colorectal cancer prevention. Pharmacoecon. Outcomes News 538, 6 (2007). https://doi.org/10.2165/00151234-200705380-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705380-00014